Nucleic Acids Research, 2001, Vol. 29, No. 16 3335-3346
© 2001 Oxford University Press
Characterization of Sp1, AP-1, CBF and KRC binding sites and minisatellite DNA as functional elements of the metastasis-associated mts1/S100A4 gene intronic enhancer
Department of Molecular Cancer Biology and 1Department of Cell Biology and Cancer, Institute of Cancer Biology, The Danish Cancer Society, Strandboulevarden 49, DK-2100 Copenhagen Ø, Denmark and 2Department of Internal Medicine, Department of Medical Biochemistry, Department of Medical Microbiology and Immunology and Comprehensive Cancer Center, Ohio State University, Columbus, OH 43210, USA
The mts1/S100A4 gene encodes a small acidic calcium-binding protein that is expressed in a cell-specific manner in development, tumorigenesis and certain tissues of adult mice. A composite enhancer that is active in murine mammary adenocarcinoma cells was previously identified in the first intron of the mts1/S100A4 gene. Here we present a detailed analysis of the structure and function of this enhancer in the Mts1/S100A4-expressing CSML100 and non-expressing CSML0 mouse adenocarcinoma cell lines. In CSML100 cells the enhancer activity is composed of at least six cis-elements interacting with Sp1 and AP-1 family members and CBF/AML/PEBP2 and KRC transcription factors. In addition, a minisatellite-like DNA sequence significantly contributes to the enhancer activity via interaction with abundant proteins, which likely have been described previously under the name minisatellite-binding proteins. Extensive mutational analysis of the mts1/S100A4 enhancer revealed a cooperative function of KRC and the factors binding minisatellite DNA. This is the first example of an enhancer where two nuclear factors earlier implicated in different recombination processes cooperate to activate transcription. In Mts1/S100A4-negative CSML0 cells the strength of the enhancer was 7- to 12.5-fold lower compared to that in CSML100 cells, when referred to the activities of three viral promoters. In CSML0 cells the enhancer could be activated by exogenous AP-1 and CBF transcription factors.
* To whom correspondence should be addressed. Tel: +45 35 25 73 84; Fax: +45 35 25 77 21; Email: et{at}cancer.dkPresent address: Martin A. Cohn, Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. C. Garrett, K. M. Varney, D. J. Weber, and A. R. Bresnick S100A4, a Mediator of Metastasis J. Biol. Chem., January 13, 2006; 281(2): 677 - 680. [Full Text] [PDF] |
||||
![]() |
H. Andersen, J. Mejlvang, S. Mahmood, I. Gromova, P. Gromov, E. Lukanidin, M. Kriajevska, J. K. Mellon, and E. Tulchinsky Immediate and Delayed Effects of E-Cadherin Inhibition on Gene Regulation and Cell Motility in Human Epidermoid Carcinoma Cells Mol. Cell. Biol., October 15, 2005; 25(20): 9138 - 9150. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Fernandez-Fernandez, D. B. Veprintsev, and A. R. Fersht Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor PNAS, March 29, 2005; 102(13): 4735 - 4740. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Papaceit, D. Orengo, and E. Juan Sequences Upstream of the Homologous cis-elements of the Adh Adult Enhancer of Drosophila Are Required for Maximal Levels of Adh Gene Transcription in Adults of Scaptodrosophila lebanonensis Genetics, May 1, 2004; 167(1): 289 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oukka, M. N. Wein, and L. H. Glimcher Schnurri-3 (KRC) Interacts with c-Jun to Regulate the IL-2 Gene in T Cells J. Exp. Med., January 5, 2004; 199(1): 15 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hernan, R. Fasheh, C. Calabrese, A. J. Frank, K. H. Maclean, D. Allard, R. Barraclough, and R. J. Gilbertson ERBB2 Up-Regulates S100A4 and Several other Prometastatic Genes in Medulloblastoma Cancer Res., January 1, 2003; 63(1): 140 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mazzucchelli Protein S100A4: Too Long Overlooked by Pathologists? Am. J. Pathol., January 1, 2002; 160(1): 7 - 13. [Full Text] [PDF] |
||||






